Valuation : Inogen, Inc.

Market Cap 141M 122M 115M 105M 197M 13.42B 198M 1.36B 528M 6.83B 531M 520M 22.64B P/E 2026 *
-6.97x
P/E 2027 * -11.2x
Enterprise Value 141M 122M 115M 105M 197M 13.42B 198M 1.36B 528M 6.83B 531M 520M 22.64B EV / Sales 2026 *
0.4x
EV / Sales 2027 * 0.38x
Free-Float
87.11%
Yield 2026 *
-
Yield 2027 * -
1 day-0.74%
1 week-3.79%
Current month-0.74%
1 month-17.36%
3 months-12.48%
6 months-12.62%
Current year-20.68%
1 week 5.32
Extreme 5.32
5.66
1 month 5.32
Extreme 5.32
6.93
Current year 5.32
Extreme 5.32
7.67
1 year 5.32
Extreme 5.32
9.13
3 years 4.13
Extreme 4.13
13.33
5 years 4.13
Extreme 4.13
61.78
10 years 4.13
Extreme 4.13
287.79
Manager TitleAgeSince
Chief Executive Officer 55 09/11/2023
Director of Finance/CFO 48 05/04/2026
Chief Operating Officer 56 05/07/2026
Director TitleAgeSince
Director/Board Member 66 05/08/2014
Chairman 65 28/12/2021
Director/Board Member 59 21/03/2022
Date Insider Type Main position Quantity % Market Cap. Importance
06/07/26 Free

Chief Operating Officer

-130,000 0.4802%
01/07/26 Sell

Head of Human Resources

-10,938 0.0404%
29/05/26 Sell

Head of Human Resources

-10,770 0.0398%
Change 5-day change 1-year change 3-year change Capi.($)
-0.74%-3.79%-33.29%-13.75% 141M
-1.30%-6.20%-17.89%+5.91% 188B
+1.53%+0.99%-0.83%+12.07% 118B
+2.28%+0.89%+13.50%+89.17% 63.16B
-1.91%-2.16%+26.23%+48.57% 52.01B
-0.53%-1.40%-3.04%-32.80% 50.97B
-1.01%+1.10%+19.64%-11.54% 34.02B
+0.23%-1.49% - - 30.8B
-0.72%-2.82%+37.13%-16.93% 23.83B
-3.10%-4.14%-7.50%+13.51% 23.45B
Average -0.52%-1.87%+3.77%+10.47% 58.47B
Weighted average by Cap. -0.28%-2.61%-0.06%+15.42%

Financials

2026 *2027 *
Net sales 356M 307M 289M 263M 495M 33.82B 498M 3.42B 1.33B 17.21B 1.34B 1.31B 57.05B 373M 321M 302M 275M 518M 35.36B 521M 3.57B 1.39B 17.99B 1.4B 1.37B 59.64B
Net income -20.8M -17.94M -16.88M -15.38M -28.91M -1.97B -29.07M -200M -77.66M -1B -78.09M -76.4M -3.33B -13.35M -11.52M -10.83M -9.87M -18.56M -1.27B -18.66M -128M -49.84M -644M -50.12M -49.04M -2.14B
Net Debt - -
Logo Inogen, Inc.
Inogen, Inc. is a global medical technology company offering respiratory products for use in the homecare setting. The Company partners with patients, prescribers, home medical equipment providers, and distributors to make its respiratory therapy products available. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators (POCs), used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. It also distributes the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure (CPAP) masks in the United States. Its proprietary Inogen One and Inogen Rove POC systems concentrate the air around the patient to offer a source of supplemental oxygen 24 hours a day, seven days a week with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available.
Employees
753
Date Price Change Volume
01/09/26 US$5.330 -0.74% 247,036
31/08/26 US$5.370 -2.36% 306,551
28/08/26 US$5.500 -0.18% 200,198
27/08/26 US$5.510 -0.90% 197,514
26/08/26 US$5.560 +0.36% 230,851
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
5.330USD
Average target price
12.00USD
Spread / Average Target
+125.14%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INGN Stock